Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000905148-20-001030
Filing Date
2020-09-18
Accepted
2020-09-18 17:05:08
Documents
1
Period of Report
2020-09-16

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3757
  Complete submission text file 0000905148-20-001030.txt   5024
Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Issuer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address
Wessels Gregory S. (Reporting) CIK: 0001824615 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39069 | Film No.: 201184601